期刊文献+

甲型H1N1流感疫苗接种对其暴发疫情的影响 被引量:1

Effect of influenza A(H1N1) vaccine against influenza outbreak
原文传递
导出
摘要 目的了解甲型H1N1流感(甲流)疫苗接种后对甲流暴发疫情的影响。方法对2011年4—5月发生在学校的1起甲流暴发疫情进行流行病学描述性分析,用回顾性队列研究的方法分析甲流疫苗接种对该起暴发疫情的影响。结果该校542名师生中191人患病,罹患率为35.24%,发病时间主要集中在4月19—25日,发病人群主要为1~6年级的小学生(χ2=9.972,P<0.01),住校生发病高于非住校生,112名接种过甲流疫苗的师生发病率为16.96%,明显低于未接种疫苗的师生(40%),差异有统计学意义(χ2=20.661,P<0.05),OR=0.306(95%CI∶0.180~0.521)。结论接种甲流疫苗可以有效预防甲型H1N1流感的发生,减少暴发疫情的发病率。 [Objective]To understand the effect of influenza A(H1N1) vaccine against influenza A outbreak.[Methods]An outbreak of influenza A occurred in a school from April to March 2011 was studied by the epidemiological descriptive analysis,and the effect of influenza A(H1N1) vaccine on this outbreak was analyzed by the retrospective cohort study.[Results]Among 542 students and teachers in this school,there were 191 patients with the attack rate of 35.24%.Most of cases occurred from 19 to 25 April,and patients were mainly pupils in grades 1-6(χ2=9.972,P〈0.01).The attack rate of resident students was higher than that of non-resident students.The incidence rate of 112 students and teachers who had received influenza A vaccine was 16.96%,which was lower than that of students and teachers who had not received vaccine(40%),and the difference was significant(χ2=20.661,P〈0.05;OR=0.306,95% CI was 0.180~0.521).[Conclusion]The influenza A vaccine can effectively prevent influenza A(H1N1),and reduce the incidence of outbreak.
出处 《职业与健康》 CAS 2012年第12期F0002-F0002,F0003,共2页 Occupation and Health
关键词 甲型H1N1流感 疫苗 暴发疫情 影响 Influenza A(H1N1); Vaccine; Outbreak; Effect
  • 相关文献

参考文献5

二级参考文献27

  • 1邹晓忠,吴石均,陈志强,李小向,高立.一起学生甲3型流行性感冒爆发的调查[J].中国学校卫生,2005,26(6):473-474. 被引量:5
  • 2李红育,于德山,邸宏杰,刘学珍,冯淑梅,张广业,蒋建祥.甘肃省1999~2004年健康人群流感抗体监测分析[J].卫生职业教育,2005,23(23):69-70. 被引量:3
  • 3卫生部.甲型H1N1流感诊疗方案(2009年试行版2版)[Z].2009,5.10.
  • 4Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenieity of 2009 pandemic influenza A HINl vaccines in China: a muhicentre, double - blind, randomised, placebo - controlled trial [J]. Lancet, 2009, 375 (15): 56-66.
  • 5Kawsar R. Talaat, Michael E. Greenberg, Michael H. Lai, et al. A Single Dose of Unadjuvanted Novel 2009 Hl N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults [ J]. The Journal of Infectious Diseases, 2010, 202 (9) : 1327 - 1337.
  • 6Committee for Medicinal Products for Human Use, Note for guidance on harmonisation of requirements for influenza vaccines, CPMP/ BWP/214/96, issued 12 March 1997. Available at: www. emea. europa, eu/pdfs/human/bwp/021496en, pdf (accessed 2 December 2009).
  • 7Food and Drug Administration. Influenza A ( Hl NI ) 20139 Monovalent Vaccine. Available at: ht~: //www. fda. gov/downloads/ biologicsbloodvaccines/vaccines/approvedproducts/uem182401, pdf.
  • 8Biao Di, Xinhong Xu, Ties~ng Li, et al. Inrnunogenicity Associated with the Routine Use of an Influenza A H1N1 Vaccine in Health Care Personnd in Guangzhou, China [ J ]. Clinical and vaccine immunology, 2010, 17 (9) : 14.78 -1480.
  • 9Vajo Z, Tamas F, Sinka L, et al. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009 -10 influenza season: a multlcentre, randomised controlled trial [J]. Lancet, 2010, 375 (15) : 49-55.
  • 10Center for Disease Control and Prevention(CDC). Safty of influenza A (H1N1)2009 monovalent vaccines. United States,October 1 November 24,2009[J]. MMWR Morb Morb Mortal Wkly Rep,2009,58: 1351 - 1356.

共引文献15

同被引文献20

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部